0 43 eps expected for phibro animal health corporation pahc


$0.43 EPS Expected for Phibro Animal Health Corporation (PAHC)


April 10, 2018 – By Migdalia James

Investors sentiment decreased to 1.41 in 2017 Q4. Its down 0.07, from 1.48 in 2017Q3. It dived, as 17 investors sold Phibro Animal Health Corporation shares while 42 reduced holdings. 25 funds opened positions while 58 raised stakes. 19.14 million shares or 1.25% less from 19.38 million shares in 2017Q3 were reported.

Price T Rowe Assoc Md invested 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC). Capital Fund Management Sa has 7,858 shares for 0% of their portfolio. Commercial Bank Of America Corporation De stated it has 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC). Goldman Sachs Group stated it has 476,391 shares. Arizona State Retirement Systems owns 0.01% invested in Phibro Animal Health Corporation (NASDAQ:PAHC) for 32,914 shares. Denali Advsrs Ltd Liability Corporation accumulated 10 shares or 0% of the stock. Polaris Cap Lc owns 115,622 shares. Blackrock Inc stated it has 2.74M shares. 6,679 are owned by Teacher Retirement Systems Of Texas. Assetmark invested in 0% or 7 shares. Metropolitan Life Ins Ny holds 6,518 shares. Royal Bank Of Canada holds 0% or 173 shares. State Street Corporation holds 0% of its portfolio in Phibro Animal Health Corporation (NASDAQ:PAHC) for 542,790 shares. Int Gp Incorporated has 15,689 shares. Legal General Grp Inc Incorporated Public Ltd Co holds 0% in Phibro Animal Health Corporation (NASDAQ:PAHC) or 35,471 shares.

Since February 9, 2018, it had 0 insider buys, and 13 sales for $12.62 million activity. BFI Co. – LLC sold $1.38M worth of stock or 36,000 shares. Bendheim Daniel M also sold $926,717 worth of Phibro Animal Health Corporation (NASDAQ:PAHC) on Thursday, March 8. $1.93 million worth of Phibro Animal Health Corporation (NASDAQ:PAHC) was sold by Miller Larry Lee. 10,000 shares were sold by Warras Dean J, worth $356,200 on Friday, February 9.



Analysts expect Phibro Animal Health Corporation (NASDAQ:PAHC) to report $0.43 EPS on May, 14.They anticipate $0.06 EPS change or 16.22 % from last quarter’s $0.37 EPS. PAHC’s profit would be $17.28 million giving it 23.60 P/E if the $0.43 EPS is correct. After having $0.44 EPS previously, Phibro Animal Health Corporation’s analysts see -2.27 % EPS growth. The stock decreased 2.29% or $0.95 during the last trading session, reaching $40.6. About 184,474 shares traded or 79.47% up from the average. Phibro Animal Health Corporation (NASDAQ:PAHC) has risen 41.44% since April 10, 2017 and is uptrending. It has outperformed by 29.89% the S&P500.

Phibro Animal Health Corporation (NASDAQ:PAHC) Ratings Coverage

Among 3 analysts covering Phibro Animal Health (NASDAQ:PAHC), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Phibro Animal Health had 3 analyst reports since February 6, 2018 according to SRatingsIntel. Piper Jaffray maintained it with “Buy” rating and $45.0 target in Wednesday, February 7 report. The company was maintained on Tuesday, February 6 by Credit Suisse. Morgan Stanley maintained it with “Underweight” rating and $36 target in Wednesday, February 7 report.

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition firm primarily in the United States. The company has market cap of $1.63 billion. It operates through three divisions: Animal Health, Mineral Nutrition, and Performance Products. It has a 26.4 P/E ratio. The firm develops, makes, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Phibro Animal Health Corporation (NASDAQ:PAHC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Back To Top